Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
3.810
-0.030 (-0.78%)
At close: Feb 26, 2026, 4:00 PM EST
3.860
+0.050 (1.31%)
Pre-market: Feb 27, 2026, 7:34 AM EST

Precigen Revenue

Precigen had revenue of $2.92M in the quarter ending September 30, 2025, with 206.61% growth. This brings the company's revenue in the last twelve months to $6.31M, up 59.20% year-over-year. In the year 2024, Precigen had annual revenue of $3.93M, down -36.95%.

Revenue (ttm)
$6.31M
Revenue Growth
+59.20%
P/S Ratio
213.67
Revenue / Employee
$44,119
Employees
143
Market Cap
1.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.93M-2.30M-36.95%
Dec 31, 20236.23M-20.68M-76.87%
Dec 31, 202226.91M12.64M88.61%
Dec 31, 202114.27M-88.91M-86.17%
Dec 31, 2020103.18M12.46M13.73%
Dec 31, 201990.72M-60.46M-39.99%
Dec 31, 2018151.18M-68.29M-31.11%
Dec 31, 2017219.46M28.54M14.95%
Dec 31, 2016190.93M17.32M9.98%
Dec 31, 2015173.61M101.68M141.35%
Dec 31, 201471.93M71.13M8,891.25%
Dec 31, 2013800.00K-12.97M-94.19%
Dec 31, 201213.77M5.76M71.90%
Dec 31, 20118.01M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Monte Rosa Therapeutics181.54M
Immatics99.45M
Vir Biotechnology68.56M
Septerna22.05M
Inventiva19.93M
Zenas BioPharma15.00M
DBV Technologies5.50M
AtaiBeckley3.02M
Revenue Rankings